{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T05:16:38Z","timestamp":1777785398757,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","award":["P30CA023074"],"award-info":[{"award-number":["P30CA023074"]}],"id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","award":["ML28849"],"award-info":[{"award-number":["ML28849"]}],"id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.pdpdt.2017.10.028","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T01:01:14Z","timestamp":1509584474000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas"],"prefix":"10.1016","volume":"21","author":[{"given":"Jason M.","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie C.","family":"Zeitouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2017.10.028_bib0005","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.clinthera.2012.08.011","article-title":"Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma","volume":"34","author":"Cirrone","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0010","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaad.2014.08.001","article-title":"Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma","volume":"71","author":"Brinkhuizen","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12885-017-3286-5","article-title":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","volume":"17","author":"Sekulic","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamadermatol.2016.0780","article-title":"Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies","volume":"152","author":"Jacobsen","year":"2016","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2015.03.013","article-title":"A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma","volume":"73","author":"Sofen","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(17)30072-4","article-title":"Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial","volume":"18","author":"Dreno","year":"2017","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0040","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1634\/theoncologist.2016-0186","article-title":"Characterization and management of hedgehog pathway inhibitor-Related adverse events in patients with advanced basal cell carcinoma","volume":"21","author":"Lacouture","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0045","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.9024","article-title":"Impact of treatment breaks on vismodegib patient outcomes: exploratory analysis of the STEVIE study","volume":"33","author":"Dummer","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8100090","article-title":"Photodynamic therapy for non-Melanoma skin cancers","volume":"8","author":"Cohen","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13555-016-0116-7","article-title":"A 10-Year retrospective analysis of methyl aminolevulinate photodynamic therapy consultation at the hospital de braga","volume":"6","author":"Brito","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1684\/ejd.2015.2570","article-title":"European dermatology forum guidelines on topical photodynamic therapy","volume":"25","author":"Morton","year":"2015","journal-title":"Eur. J. Dermatol.: EJD"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/phpp.12148","article-title":"Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2015","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jocd.12236","article-title":"Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis","volume":"15","author":"Zou","year":"2016","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/lsm.20363","article-title":"A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma","volume":"38","author":"Oseroff","year":"2006","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0738-081X(01)00170-5","article-title":"Laser and photodynamic therapy in the management of cutaneous malignancies","volume":"19","author":"Zeitouni","year":"2001","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archderm.141.1.60","article-title":"Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy","volume":"141","author":"Oseroff","year":"2005","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0090","first-page":"1054","article-title":"Delta-aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome","volume":"30","author":"Itkin","year":"2004","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0095","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0100","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2217\/fon.15.208","article-title":"Photodynamic therapy for basal cell carcinoma","volume":"11","author":"Fargnoli","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0105","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ad.2016.04.020","article-title":"Resistance of nonmelanoma skin cancer to nonsurgical treatments part II: photodynamic therapy, vismodegib, cetuximab, intralesional methotrexate, and radiotherapy","volume":"107","author":"Gracia-Cazana","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jdv.13453","article-title":"Er :YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"30","author":"Choi","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol: JEADV"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0115","unstructured":"E. Epstein, ClinicalTrials.gov Identifier: NCT01556009. In, 2015."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0120","series-title":"Personal Communication. In","author":"Epstein","year":"2017"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0125","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/DSS.0000000000000183","article-title":"A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer","volume":"40","author":"Zeitouni","year":"2014","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pdpdt.2016.09.006","article-title":"Penetration of 630nm laser and 5-aminolevulinic acid in tissue with intralesional photodynamic therapy","volume":"16","author":"Suarez-Valladares","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10103-014-1609-1","article-title":"Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma","volume":"30","author":"Samy","year":"2015","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/DSS.0000000000000633","article-title":"Daylight photodynamic therapy: what is known and what is yet to be determined","volume":"42","author":"Fitzmaurice","year":"2016","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lsm.22429","article-title":"Witjes MJ. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: case and literature review","volume":"47","author":"Horlings","year":"2015","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2217\/fon-2016-0296","article-title":"Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma","volume":"13","author":"Fife","year":"2017","journal-title":"Future Oncol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/lsm.22118","article-title":"A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer","volume":"45","author":"Zeitouni","year":"2013","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaad.2015.12.009","article-title":"Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study","volume":"74","author":"Kessels","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2340\/00015555-2273","article-title":"Patient preferences for treatment of basal cell carcinoma: importance of cure and cosmetic outcome","volume":"96","author":"Martin","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0175","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ijc.25411","article-title":"Trends in the incidence of nonmelanoma skin cancer in Denmark 1978\u20132007: Rapid incidence increase among young Danish women","volume":"127","author":"Birch-Johansen","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0180","first-page":"542","article-title":"Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer","volume":"32","author":"Cohen","year":"2006","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0185","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0190-9622(90)70344-H","article-title":"Histologic pattern analysis of basal cell carcinoma: study of a series of 1039 consecutive neoplasms","volume":"23","author":"Sexton","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2133.2002.04804.x","article-title":"Variations of basal cell carcinomas according to gender, age, location and histopathological subtype","volume":"147","author":"Scrivener","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2010.03839.x","article-title":"Trends in the incidence of basal cell carcinoma by histopathological subtype","volume":"25","author":"Arits","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"key":"10.1016\/j.pdpdt.2017.10.028_bib0200","first-page":"686","article-title":"Gender differences in tumor and patient characteristics in those undergoing Mohs surgery","volume":"40","author":"Lee","year":"2014","journal-title":"Dermatol. Surg."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100017304301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100017304301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:30:52Z","timestamp":1761611452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100017304301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"alternative-id":["S1572100017304301"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2017.10.028","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2017.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}